FDA Drug Application (020264) for MEGACE by BRISTOL MYERS SQUIBB

Back to FDA Applications sponsored by BRISTOL MYERS SQUIBB

Application Number020264
Product Number001
FormSUSPENSION;ORAL
Dosage40MG/ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameMEGACE
Active IngredientMEGESTROL ACETATE

Active IngredientCount
List of drugs with Active Ingredient MEGESTROL ACETATE3


Back to FDA Applications sponsored by BRISTOL MYERS SQUIBB